{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "HTLV-1",
      "leucocyte reduction",
      "proviral load",
      "transfusion",
      "transfusion-transmitted infection"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "25930000",
  "DateCompleted": {
    "Year": "2016",
    "Month": "02",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "12",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2015",
        "Month": "04",
        "Day": "30"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1111/vox.12263"
    ],
    "Journal": {
      "ISSN": "1423-0410",
      "JournalIssue": {
        "Volume": "109",
        "Issue": "2",
        "PubDate": {
          "Year": "2015",
          "Month": "Aug"
        }
      },
      "Title": "Vox sanguinis",
      "ISOAbbreviation": "Vox Sang"
    },
    "ArticleTitle": "Estimation of the infectious viral load required for transfusion-transmitted human T-lymphotropic virus type 1 infection (TT-HTLV-1) and of the effectiveness of leukocyte reduction in preventing TT-HTLV-1.",
    "Pagination": {
      "StartPage": "122",
      "EndPage": "128",
      "MedlinePgn": "122-8"
    },
    "Abstract": {
      "AbstractText": [
        "The risk of transfusion-transmitted human T-lymphotropic virus type 1 infection (TT-HTLV-1) after prestorage leucocyte reduction (LR) remains unknown, as the proviral load in the blood component that would cause TT-HTLV-1 is undetermined. On the basis of the distribution of HTLV-1 proviral load among HTLV-1-sero-positive blood donors, we attempted to estimate the proviral load for transfusion-related infectivity. We also discuss the effectiveness of LR in preventing TT-HTLV-1.",
        "The HTLV-1 proviral load in 300 HTLV-1-sero-positive blood donors was determined by real-time polymerase chain reaction analysis. The proviral load required for transfusion-related infectivity was estimated using historical TT-HTLV-1 frequency data from a retrospective study on patients who had received blood from HTLV-1-sero-positive blood donors and the distribution pattern of HTLV-1 proviral load among blood donors.",
        "HTLV-1 proviral loads ranged between < 0.01 and 25.0 copies per 100 leucocytes. Historical data showed TT-HTLV-1 frequency to be 80%. Assuming that 80% of the 300 sero-positive samples are infectious, it is estimated that the transfer of \u2265 9 \u00d7 10(4) cells containing the HTLV-1 provirus is required to establish TT-HTLV-1.",
        "The residual number of HTLV-1-infected cells after LR is substantially lower than the viral load necessary for TT-HTLV-1. LR therefore appears to be effective in minimizing the incidence of TT-HTLV-1."
      ],
      "CopyrightInformation": "\u00a9 2015 International Society of Blood Transfusion."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan."
          }
        ],
        "LastName": "Sobata",
        "ForeName": "R",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan."
          }
        ],
        "LastName": "Matsumoto",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan."
          }
        ],
        "LastName": "Uchida",
        "ForeName": "S",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan."
          }
        ],
        "LastName": "Suzuki",
        "ForeName": "Y",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan."
          }
        ],
        "LastName": "Satake",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan."
          }
        ],
        "LastName": "Tadokoro",
        "ForeName": "K",
        "Initials": "K"
      }
    ],
    "PublicationTypeList": [
      "Evaluation Study",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Vox Sang",
    "NlmUniqueID": "0413606",
    "ISSNLinking": "0042-9007"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "DNA, Viral"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "DNA, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "prevention & control",
        "transmission"
      ],
      "DescriptorName": "HTLV-I Infections"
    },
    {
      "QualifierName": [
        "genetics",
        "isolation & purification",
        "pathogenicity"
      ],
      "DescriptorName": "Human T-lymphotropic virus 1"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Leukocyte Reduction Procedures"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Transfusion Reaction"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Viral Load"
    }
  ]
}